Angelalign Technology (SEHK:6699) Earnings Surge Challenges Concerns Over Long Term Decline

Simply Wall St.03-29

Angelalign Technology (SEHK:6699) opened FY 2025 with first half revenue of US$161.4 million and basic EPS of US$0.09, setting up its latest earnings release against a year of sharply higher reported ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623627331?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-03-29 09:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623627331","market":"sg","top_or_hot":-1,"title":"Angelalign Technology (SEHK:6699) Earnings Surge Challenges Concerns Over Long Term Decline","media":"Simply Wall St.","content":"<div>\n<p>Angelalign Technology (SEHK:6699) opened FY 2025 with first half revenue of US$161.4 million and basic EPS of US$0.09, setting up its latest earnings release against a year of sharply higher reported ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-earnings-surge-challenges-con\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Angelalign Technology (SEHK:6699) Earnings Surge Challenges Concerns Over Long Term Decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAngelalign Technology (SEHK:6699) Earnings Surge Challenges Concerns Over Long Term Decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-29 09:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-earnings-surge-challenges-con><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Angelalign Technology (SEHK:6699) opened FY 2025 with first half revenue of US$161.4 million and basic EPS of US$0.09, setting up its latest earnings release against a year of sharply higher reported ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-earnings-surge-challenges-con\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-earnings-surge-challenges-con","article_id":"2623627331","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-earnings-surge-challenges-con","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2623627331","pubTimestamp":1774746777,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Angelalign Technology (SEHK:6699) opened FY 2025 with first half revenue of US$161.4 million and basic EPS of US$0.09, setting up its latest earnings release against a year of sharply higher reported earnings and a stronger net profit margin. The company has seen revenue move from US$121.3 million and EPS of US$0.02 in 1H 2024 to US$150.8 million and EPS of US$0.05 in 2H 2024, while trailing twelve month EPS reached US$0.17 and net profit margin improved to 7.7%, which points to cleaner...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1100":"医疗保健设备","BK1593":"医美概念股","BK1587":"次新股","06699":"时代天使","BK1583":"高瓴概念"},"translate_title":"时代天使科技（SEHK：6699）盈利飙升挑战长期下滑的担忧","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06699":0.9},"content_text":"Angelalign Technology (SEHK:6699) opened FY 2025 with first half revenue of US$161.4 million and basic EPS of US$0.09, setting up its latest earnings release against a year of sharply higher reported earnings and a stronger net profit margin. The company has seen revenue move from US$121.3 million and EPS of US$0.02 in 1H 2024 to US$150.8 million and EPS of US$0.05 in 2H 2024, while trailing twelve month EPS reached US$0.17 and net profit margin improved to 7.7%, which points to cleaner profitability through the period. Against that backdrop, the latest numbers give investors a clearer read on how sustainably margins are holding up as growth expectations moderate. See our full analysis for Angelalign Technology. With the earnings picture set, the next step is to see how these results line up with the most widely held narratives around Angelalign Technology and where those stories may need updating. Curious how numbers become stories that shape markets? Explore Community Narratives SEHK:6699 Revenue & Expenses Breakdown as at Mar 2026 Advertisement134.7% earnings growth reshapes the story  Over the last 12 months, net income reached US$28.4 million and EPS reached US$0.17, compared with earlier 12 month figures of US$12.1 million and EPS of US$0.07, which lines up with the reported 134.7% earnings growth. What really backs the bullish view is that this earnings jump comes alongside a net profit margin of 7.7% versus 4.5% a year earlier. This fits the idea of a more self sustaining business but also raises the question of how that bullish case holds up against the prior five year pattern of a 16.1% annual earnings decline.\n     Bulls pointing to a growing digital dentistry platform can reference the trailing twelve month revenue of US$370.3 million versus earlier trailing revenue of US$268.8 million as support for a stronger operating base. At the same time, the long run history of declining earnings means this recent 134.7% upswing is a clear positive data point, not yet a long term pattern, so it is reasonable for bullish investors to watch whether the 7.7% margin level is maintained in future periods.    Margins and P/E both sitting at premium levels  The trailing net profit margin of 7.7% now sits alongside a P/E of 51x, compared with a peer average of 43.5x and a Hong Kong medical equipment industry average of 16.9x, so the stock is priced at a premium to both its closest group and the broader industry. Critics highlight that a premium P/E multiple can be hard to justify if growth cools, and the numbers give them some support because forecast earnings growth of 9.4% per year sits below the Hong Kong market’s 12.1% forecast even though revenue growth is expected at 14.6% per year, above the market’s 8.1%.\n     This mix of above market revenue growth but below market earnings growth fits a more cautious or bearish angle that future earnings may not rise fast enough to make a 51x P/E look comfortable against peers at 43.5x. On the other hand, the improved 7.7% margin compared with 4.5% a year earlier gives bearish investors a concrete figure to watch if they are concerned that profitability might not keep up with the current valuation premium.    DCF and targets suggest upside despite premium  Against the current share price of HK$66.55, the supplied DCF fair value of HK$89.07 and analyst target of HK$86.47 both sit higher. This lines up with the view that the stock trades at about a 25% discount to DCF and that analyst targets imply close to 30% potential upside. What is interesting for bullish and cautious investors alike is that these upside signals appear even with a premium 51x P/E. The valuation models are effectively saying that stronger revenue growth of 14.6% per year and the current 7.7% margin can still justify more than today’s price, while bears can point to the modest 9.4% forecast earnings growth and recent insider selling flagged as a risk as reasons to treat those upside references with care.\n     For readers weighing this tension, the gap between HK$66.55 and the DCF fair value of HK$89.07 is one of the key numbers to keep in mind alongside the premium P/E relative to peers and industry. Minor insider selling over the last three months adds one more data point that more cautious investors might link to the high multiple, even though no major operational risks were listed in the data provided.    For a fuller picture of how other investors are interpreting these moves in growth, margins and valuation, it helps to see how the different storylines compare in one place. Curious how numbers become stories that shape markets? Explore Community Narratives Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Angelalign Technology's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. With both risks and rewards in play, the real question is how these figures sit with your own expectations. Move quickly, review the numbers in detail, and weigh the 4 key rewards and 1 important warning sign. See What Else Is Out There Angelalign Technology combines a premium 51x P/E, slower forecast earnings growth of 9.4% versus the Hong Kong market, and recent insider selling, which together raise valuation and durability questions. If that mix of high expectations and softer growth makes you cautious, it could be time to scan for companies on the 277 resilient stocks with low risk scores that pair steadier risk profiles with fundamentals you find more comfortable.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623627331","isCrawlerRequest":true}